Article
The complement receptor 3 (CD11b/CD18) agonist Leukadherin-1 suppresses human innate inflammatory signalling.
Clinical and experimental immunology - 1 Sept 2016
Roberts A L, Fürnrohr B G, Vyse T J, Rhodes B
Abstract excerpt
Complement receptor 3 (CR3, CD11b/CD18) is a multi-functional receptor expressed predominantly on myeloid and natural killer (NK) cells. The R77H variant of CD11b, encoded by the ITGAM rs1143679 polymorphism, is associated robustly with development of the autoimmune disease systemic lupus erythematosus (SLE) and impairs CR3 function, including its regulatory role on monocyte immune signalling. The role of CR3 in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
